Cessatech A/S (NGM:CESSA)

Market Cap	293.28M
Revenue (ttm)	n/a
Net Income (ttm)	-23.10M
Shares Out	18.58M
EPS (ttm)	-1.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,105
Average Volume	15,851
Open	11.00
Previous Close	10.96
Day's Range	10.84 - 11.46
52-Week Range	6.00 - 19.20
Beta	0.51
RSI	45.31
Earnings Date	Aug 21, 2025

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CESSA

Financial Performance

Financial numbers in DKK